首页> 外文期刊>Indian drugs >FORMULATION AND EVALUATION OF LIPID BASED SELF EMULSIFYING DRUG DELIVERY SYSTEM OF GLIMEPIRIDE
【24h】

FORMULATION AND EVALUATION OF LIPID BASED SELF EMULSIFYING DRUG DELIVERY SYSTEM OF GLIMEPIRIDE

机译:基于脂质的格列吡酯自乳化药物输送系统的设计与评价

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Aim of the present investigation was to develop lipid based self-emulsifying drug delivery system (SEDDS) to improve bioavailability of glimepiride. Glimepiride is a class II molecule according to BCS (Biopharmaceutical Classification System), having low solubility. Optimized self-emulsifying drug delivery system of glimepiride comprising oil (oleic acid), surfactant (Tween 80?) and co-surfactant (PEG 200?) was prepared. Optimized SEDDS of glimepiride showed increase in dissolution rate. It was concluded that the formulation was found to be showing significant improvement in terms of the drug release with complete release of drug within 18 minutes. Thus, self-emulsifying formulation of glimepiride was successfully developed.
机译:本研究的目的是开发基于脂质的自乳化药物递送系统(SEDDS),以提高格列美脲的生物利用度。格列美脲是根据BCS(生物制药分类系统)的II类分子,具有低溶解度。制备了包含油(油酸),表面活性剂(吐温80?)和助表面活性剂(PEG 200?)的格列美脲的优化的自乳化药物递送系统。优化的格列美脲的SEDDS显示溶出度增加。结论是,发现该制剂在药物释放方面显示出显着的改善,在18分钟内药物完全释放。因此,成功开发了格列美脲的自乳化制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号